UnitedHealth Purchases Pharmacy Genoa Healthcare From Advent
(Bloomberg) -- UnitedHealth Group Inc. bought pharmacy company Genoa Healthcare from private equity group Advent International. The price was about $2.5 billion, according to a person familiar with the transaction.
UnitedHealth, the biggest U.S. health insurer, beat out other parties including drugstore chain Walgreens Boots Alliance, which was said to be interested in Genoa in August, according to the person, who requested anonymity because the talks were private.
Genoa runs more than 425 pharmacies in behavioral-health centers in 46 states, according to its website, serving more than 650,000 people. It also has a team of more than 250 psychiatrists and nurse practitioners who provide telepsychiatry services to mental-health patients.
The company will be wrapped into UnitedHealth's pharmacy benefit group OptumRx to improve care for patients with behavioral health and substance-abuse problems, according to a statement from UnitedHealth confirming the deal.
A representative for Advent declined to comment. The Boston-based firm bought an 80 percent stake in Genoa in 2015.
To contact the reporters on this story: John Tozzi in New York at jtozzi2@bloomberg.net;Kiel Porter in New York at kporter17@bloomberg.net;Zachary Tracer in New York at ztracer1@bloomberg.net
To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, ;Elizabeth Fournier at efournier5@bloomberg.net, Mark Schoifet
©2018 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.